Skip to content

Addiction: all studies

Page 383 of 860: studies 3,821 to 3,830 of 8,594, newest first. Back to the addiction overview

Research

Ibogaine and Noribogaine

The Oxford Handbook of Opioids and Opioid Use Disorder December 18, 2023 Deborah C. Mash, Michael Karukin

Abstract Ibogaine is an indole alkaloid derived from the root bark of Tabernanthe iboga. The anti-addictive actions of ibogaine were first reported in the 1960s by persons using heroin. They offered personal testimonials that single oral doses of ibogaine abruptly blocked opioid withdrawal, and they remained drug-free after ibogaine exposure. Today, online forums describe ibogaine use for...

Efeitos do tratamento com Ibogaína em dependentes de opióides: uma revisão integrativa

Brazilian Journal of Health Review December 15, 2023 Fernanda Leticia Dos Santos Matta, Vivian Frigo Batista, Alexandre Dantas Gimenes et al.

A Ibogaína é um alcalóide indólico psicoativo com efeitos estimulantes e alucinógenos o qual é derivado da casca da raiz do arbusto da África Ocidental Tabernanthe iboga, mostra-se uma alternativa promissora no tratamento de dependentes de substâncias derivadas do ópio por demonstrar uma afinidade significativa por muitos sistemas neurotransmissores. Avaliar os efeitos do tratamento com...

DOI: 10.34119/bjhrv6n6-415 (opens in new tab) Gynecology Pediatrics Anesthesia

An Accumulating Neural Signal Underlying Binocular Rivalry Dynamics.

Journal of Neuroscience December 13, 2023 Shaozhi Nie, Sucharit Katyal, Stephen A Engel

During binocular rivalry, conflicting images are presented one to each eye and perception alternates stochastically between them. Despite stable percepts between alternations, modeling suggests that neural signals representing the two images change gradually, and that the duration of stable percepts are determined by the time required for these signals to reach a threshold that triggers an...

DOI: 10.1523/jneurosci.1325-23.2023 (opens in new tab) Full text (opens in new tab) Ssvep Binocular rivalry Bistable perception Drift-diffusion +1

Personality explains the relationship between psychedelic use and depression; a comparison study with non psychedelic users

Research Square December 13, 2023 David Sjöström, Emma Claesdotter-Knutsson, Petri Kajonius preprint

Abstract Interest in psychedelics is increasing due to potential for improved mental health and quality of life. However, adverse effects on mental health are still a concern. Personality traits have been suggested to both influence the psychedelic experience and mental health, and even be changed by psychedelic use. The present study describes for the first time a national sample of Swedish...

DOI: 10.21203/rs.3.rs-3714546/v1 (opens in new tab) Full text (opens in new tab) Neuroticism Openness to experience Mental health Clinical psychology +1

Psychedelics and cognitive function: A systematic review

Research, Society and Development December 13, 2023 Caíque Gois Cardoso, Milena de Barros Viana 2 citations

Introduction: With the progressive advancement of clinical and experimental trials aimed at investigating the pharmacotherapeutic potential of psychedelic substances, there is also the development of other conceptions of use, not only for the treatment of psychiatric disorders, but also for the improvement of emotional/cognitive functions. Objective: The present study is a systematic review of...

Psilocybin prevents activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms

bioRxiv (Cold Spring Harbor Laboratory) December 13, 2023 Kyna‐anne Conn, Lk Milton, Kaixin Huang et al. 6 citations preprint

Abstract Psilocybin has shown promise for alleviating symptoms of depression and is currently in clinical trials for the treatment of anorexia nervosa (AN), a condition that is characterised by persistent cognitive inflexibility. Considering that enhanced cognitive flexibility after psilocybin treatment is reported to occur in individuals with depression, it is plausible that psilocybin could...

DOI: 10.1101/2023.12.12.571374 (opens in new tab) Full text (opens in new tab) Psilocybin Cognitive flexibility Cognition Flexibility engineering +5

Exploring the Unique Therapeutic Potential of Psychedelics to Reduce Chronic Shame Among Sexual and Gender Minority Adults.

Psychedelic Medicine December 13, 2023 Nicholas A. Carlisle, Haley Maria Dourron, Sarah Maccarthy et al. 12 citations

Recent trials of psychedelic-assisted therapy have suggested potential efficacy for the treatment of many health conditions that disproportionately impact sexual and gender minority (SGM) people, including major depressive disorder and alcohol and tobacco use disorders. Despite these promising findings, the potential benefits of psychedelics for SGM people have been largely ignored. First, we...

Revisiting Alpha Resting State Dynamics Underlying Hallucinatory Vulnerability: Insights from Hidden Semi-Markov Modeling

bioRxiv (Cold Spring Harbor Laboratory) December 12, 2023 Hanna Honcamp, Michael Schwartze, Maria Amorim et al. preprint

Abstract Resting state (RS) brain activity is inherently non-stationary. Hidden Semi-Markov Models (HsMM) can characterize the continuous RS data as a sequence of recurring and distinct brain states along with their spatio-temporal dynamics. Recent explorations suggest that EEG brain state dynamics in the alpha frequency link to auditory hallucination proneness (HP) in non-clinical individuals....

DOI: 10.1101/2023.12.11.571070 (opens in new tab) Full text (opens in new tab) Electroencephalography Hidden markov model Resting State FMRI Dynamics music +7

Treatment with psychedelics is psychotherapy: beyond reductionism

The Lancet Psychiatry December 12, 2023 Gerhard Gründer, Manuela Brand, Lea J. Mertens et al. 103 citations

Treatment of psychiatric disorders with psychedelic substances represents one of the most promising current treatment approaches in psychiatry. Since its inception in the 1950s, therapy with psychedelics has been conceptualised as psychedelic-assisted psychotherapy-ie, a form of psychotherapy that uses the profound biological effects of this class of substances as a catalyst for changing...

DOI: 10.1016/s2215-0366(23)00363-2 (opens in new tab) Reductionism Psychotherapist Medline Epistemology

Psychotropics: A scientific, regulatory, and public view on the medicinal uses of cannabinoids and psilocybin

Medical Writing December 11, 2023 Ivana Turek 1 citation

Research on psychotropics is gaining more popularity worldwide and support from drug regulatory agencies, which recognise the unmet medical needs of certain patient communities, such as patients with mental disorders and patients with cancer who experience depression. Cannabinoids and psilocybin have shown promising results in preclinical studies and clinical trials, but the current clinical...

DOI: 10.56012/tsen2260 (opens in new tab) Full text (opens in new tab) Psilocybin Clinical trial Regulatory science Marketing authorization +3